跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Phenylacetate
首页
药物
Phenylacetate
Phenylacetate
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compositions Comprising Ornithine And Phenylacetate Or Phenylbutyrate For Treating Hepatic Encephalopathy
US 2008119554 A1
申请人: JALAN RAJIV
优先权: 2004
EP
US
WO
8 件公开
METHODS FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA (RGBM)
EP 3621600 A4
申请人: BURZYNSKI STANISLAW R
优先权: 2017
CN
EP
US
8 件公开
5'-O-PHENYLACETYLURIDINE AND THERAPEUTIC USE
EP 4255563 A4
申请人: PHARMA CINQ LLC
优先权: 2020
EP
US
WO
6 件公开
L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF
EP 3263100 B1
申请人: OCERA THERAPEUTICS INC
优先权: 2009
CN
EP
6 件公开
DOSAGES AND USES OF ORNITHINE PHENYLACETATE FOR TREATING HYPERAMMONEMIA
EP 4045028 A4
申请人: OCERA THERAPEUTICS INC
优先权: 2019
CN
EP
US
WO
5 件公开
TREATMENT OF INFLAMMATION USING L-ORNITHINE PHENYLACETATE
EP 3517110 A1
申请人: UCL BUSINESS PLC
优先权: 2009
CN
EP
US
5 件公开
PHENYLBUTYRATE FOR THE TREATMENT OF MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
EP 2838522 B1
申请人: UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION
优先权: 2012
EP
US
5 件公开
TREATMENT AND PREVENTION OF MUSCLE LOSS USING L-ORNITHINE IN COMBINATION WITH AT LEAST ONE OF PHENYLACETATE AND PHENYLBUTYRATE
EP 3337473 A4
申请人: OCERA THERAPEUTICS INC
优先权: 2015
EP
US
WO
3 件公开
PPAR-GAMMA ACTIVATORS AND THEIR THERAPEUTICAL USAGES
EP 3383384 A4
申请人: THERIAC BIOMEDICALE INC
优先权: 2015
CN
EP
US
3 件公开
MODULATION OF IN VIVO GLUTAMINE AND GLYCINE LEVELS IN THE TREATMENT OF AUTISM
WO 0141707 A3
申请人: UNIV VANDERBILT
优先权: 1999
US
WO
3 件公开
第 1 / 8 页
上一页
下一页
药物
反馈